The PPRD score stratifies patients with hepatocellular carcinoma and portal vein tumor thrombus treated with sorafenib plus transarterial chemoembolization

被引：0
|
作者：
Yingqiang Zhang
Hongfei Miao
Wenlin Xie
Suxiang Jiang
Ze Song
Guihua Huang
Wenzhe Fan
Yu Wang
Jiaping Li
Yong Chen
机构：
[1] Nanfang Hospital,Division of Vascular and Interventional Radiology, Department of General Surgery
[2] Southern Medical University,Department of Interventional Radiology, The Seventh Affiliated Hospital
[3] Sun Yat-sen University,Department of Pathology, The Seventh Affiliated Hospital
[4] Sun Yat-sen University,Department of Radiology, The Seventh Affiliated Hospital
[5] Sun Yat-sen University,Department of Oncology, The Seventh Affiliated Hospital
[6] Sun Yat-sen University,Digestive Medicine Center, The Seventh Affiliated Hospital
[7] Sun Yat-sen University,Department of Interventional Oncology, The First Affiliated Hospital
[8] Sun Yat-sen University,undefined
来源：
European Radiology | 2021年 / 31卷
关键词：
Carcinoma, hepatocellular; Tumor thrombus; Chemoembolization, therapeutic; Sorafenib; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：232 / 243
页数：11
相关论文
共 50 条
  • [41] Transarterial chemoembolization combined with sorafenib and iodine-125 seed brachytherapy for hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
    Huang, Jingjun
    Cai, Mingyue
    Huang, Wensou
    Guo, Yongjian
    Zhou, Jingwen
    Liang, Licong
    Lin, Liteng
    Zhou, Zhimei
    Lian, Hui
    He, Mingji
    Zhu, Kangshun
    [J]. CHINESE MEDICAL JOURNAL, 2022, 135 (01) : 113 - 115
  • [42] Endovascular brachytherapy combined with portal vein stenting and transarterial chemoembolization improves overall survival of hepatocellular carcinoma patients with main portal vein tumor thrombus
    Yu, Tian-Zhu
    Zhang, Wen
    Liu, Qing-Xin
    Li, Wen-Hui
    Ma, Jing-Qin
    Zhang, Zi-Han
    Yang, Min-Jie
    Wang, Jian-Hua
    Chen, Bing
    Zeng, Shao-Chong
    Luo, Jian-Jun
    Liu, Ling-Xiao
    Yan, Zhi-Ping
    [J]. ONCOTARGET, 2017, 8 (07) : 12108 - 12119
  • [43] Adjuvant transarterial chemoembolization with sorafenib for patients with hepatocellular carcinoma with portal vein tumor thrombus after surgery: A phase III, multicenter, randomized, controlled trial.
    Kuang, Ming
    Peng, Zhenwei
    Fan, Wenzhe
    Liu, Zelong
    Xiao, Han
    Tu, Jianfei
    Tang, Rong
    Huang, Zhen
    Cheng, Yu
    Li, Fuliang
    Lu, Mingjian
    Li, Jiaping
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 493 - 493
  • [44] Sorafenib With and Without Transarterial Chemoembolization for Advanced Hepatocellular Carcinoma With Main Portal Vein Tumor Thrombosis: A Retrospective Analysis
    Zhang, Yingqiang
    Fan, Wenzhe
    Wang, Yu
    Lu, Ligong
    Fu, Sirui
    Yang, Jianyong
    Huang, Yonghui
    Yao, Bwang
    Li, Jiaping
    [J]. ONCOLOGIST, 2015, 20 (12): : 1417 - 1424
  • [45] Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
    Lee, Jung Min
    Jang, Byoung Kuk
    Lee, Yoo Jin
    Choi, Wang Yong
    Choi, Sei Myong
    Chung, Woo Jin
    Hwang, Jae Seok
    Kang, Koo Jeong
    Kim, Young Hwan
    Chauhan, Anil Kumar
    Park, Soo Young
    Tak, Won Young
    Kweon, Young Oh
    Kim, Byung Seok
    Lee, Chang Hyeong
    [J]. CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (01) : 160 - 167
  • [46] Transarterial chemoembolization versus best supportive care for patients with hepatocellular carcinoma with portal vein tumour thrombus
    Xiang, Xiao
    Zhong, Jian-Hong
    Cheng, Qian
    Li, Zhao
    Li, Le-Qun
    Zhu, Ji-Ye
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E594 - E594
  • [47] Chemoembolization Plus Radiotherapy versus Chemoembolization Plus Sorafenib for the Treatment of Hepatocellular Carcinoma Invading the Portal Vein: A Propensity Score Matching Analysis
    Chu, Hee Ho
    Kim, Jin Hyoung
    Shim, Ju Hyun
    Yoon, Sang Min
    Kim, Pyeong Hwa
    Alrashidi, Ibrahim
    [J]. CANCERS, 2020, 12 (05)
  • [48] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Zhang, Lei
    Sun, Jun-Hui
    Hou, Zhong-Heng
    Zhong, Bin-Yan
    Yang, Min-Jie
    Zhou, Guan-Hui
    Wang, Wan-Sheng
    Huang, Peng
    Zhang, Shen
    Li, Zhi
    Zhu, Xiao-Li
    Yan, Zhi-Ping
    Ni, Cai-Fang
    [J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2021, 44 (01) : 63 - 72
  • [49] Prognosis Nomogram for Hepatocellular Carcinoma Patients with Portal Vein Invasion Undergoing Transarterial Chemoembolization Plus Sorafenib Treatment: A Retrospective Multicentre Study
    Lei Zhang
    Jun-Hui Sun
    Zhong-Heng Hou
    Bin-Yan Zhong
    Min-Jie Yang
    Guan-Hui Zhou
    Wan-Sheng Wang
    Peng Huang
    Shen Zhang
    Zhi Li
    Xiao-Li Zhu
    Zhi-Ping Yan
    Cai-Fang Ni
    [J]. CardioVascular and Interventional Radiology, 2021, 44 : 63 - 72
  • [50] An exploratory study of sorafenib plus toripalimab for unresectable hepatocellular carcinoma with portal vein tumor thrombus.
    Yang, Yu
    Li, Qiu
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345